At DeviceTalks Minnesota 2018, medtech veteran Michael Pederson provided an inside look at the Abbott-St. Jude Medical merger and what’s ahead for Abbott’s cardiovascular technologies.
IN CASE YOU MISSED IT
- How COVID-19 impacts FDA interactions with medical device manufacturers
- Xeris Pharmaceuticals launches autoinjector for severe hypoglycemia
- Abbott, Tandem seal deal to combine CGM, insulin delivery tech
- Inivata launches lung cancer liquid biopsy test
- Insulet installs thousands of solar panels at global HQ